long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 21:06 (760 d 13:34 ago) – Posting: # 21342
Views: 1,218

Hi,

» But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.

Have you found out why the increase in half-life?

J

Complete thread:

UA Flag
Activity
 Admin contact
22,091 posts in 4,630 threads, 1,566 registered users;
online 13 (0 registered, 13 guests [including 10 identified bots]).
Forum time: Sunday 10:40 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5